FDA Inspection 1244007 — LFB USA, Inc.

LFB USA, Inc. — FEI 3013501870

The FDA completed an inspection of LFB USA, Inc. on Jun 28, 2024 in Charlton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 28, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Charlton, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.